Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MRVI | US
-0.01
-0.13%
Healthcare
Biotechnology
30/06/2024
04/10/2024
7.89
7.70
7.90
7.62
Maravai LifeSciences Holdings Inc. a life sciences company provides products to enable the development of drug therapies diagnostics novel vaccines and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications antibody-based products to detect impurities during the production of biopharmaceutical products and products to detect the expression of proteins in tissues of various species. It operates in two segments Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy nucleoside chemistry oligonucleotide therapy and molecular diagnostics including reagents used in the chemical synthesis modification labelling and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA oligonucleotides and oligonucleotide building blocks as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits other bioprocess impurity and contaminant ELISA kits ancillary reagents Viral Clearance Prediction kits and custom services. It serves biopharmaceutical companies and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego California.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
40.1%1 month
57.4%3 months
70.1%6 months
65.7%-
344.83
2.73
1.29
0.39
1.69
4.24
-
2.07M
1.99B
1.99B
-
-14.59
-32.70
6.50
-19.39
2.93
6.67
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.37
Range1M
1.98
Range3M
3.19
Rel. volume
0.44
Price X volume
5.54M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Novavax Inc | NVAX | Biotechnology | 13.61 | 2.18B | -7.29% | n/a | -54.03% |
Vericel Corporation | VCEL | Biotechnology | 43.36 | 2.17B | 6.54% | 4.32K | 39.42% |
Centessa Pharmaceuticals plc American Depositary Shares | CNTA | Biotechnology | 15.94 | 2.05B | -1.97% | n/a | 29.85% |
Akero Therapeutics Inc | AKRO | Biotechnology | 28.24 | 2.04B | -3.32% | n/a | 4.54% |
Celldex Therapeutics Inc | CLDX | Biotechnology | 30.65 | 2.03B | 1.46% | n/a | 0.29% |
Harmony Biosciences Holdings Inc. | HRMY | Biotechnology | 34.6 | 2.00B | -2.73% | 20.07 | 40.71% |
Ligand Pharmaceuticals Incorporated | LGND | Biotechnology | 104.78 | 1.95B | 4.83% | 42.52 | 0.98% |
BEAM THERAPEUTICS INC. | BEAM | Biotechnology | 23.41 | 1.93B | -0.38% | n/a | 19.35% |
Galapagos NV | GLPG | Biotechnology | 29.19 | 1.92B | 2.89% | 55.25 | 0.00% |
Mirum Pharmaceuticals Inc | MIRM | Biotechnology | 39.26 | 1.87B | -5.37% | n/a | 138.24% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 40.42 | 1.68B | 0.17% | 42.66 | 64.69% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 57.84 | 1.66B | 0.98% | 21.48 | 56.33% |
Steelcase Inc | SCS | Building Products & Equipment | 12.97 | 1.47B | 0.78% | 12.50 | 65.47% |
REV Group Inc | REVG | Recreational Vehicles | 27.56 | 1.43B | 0.00% | 6.15 | 63.13% |
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 1.69 | 0.76 | Expensive |
Ent. to Revenue | 4.24 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 2.73 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 70.11 | 74.67 | Par |
Debt to Equity | 1.29 | -1.82 | Expensive |
Debt to Assets | 0.39 | 0.26 | Expensive |
Market Cap | 1.99B | 3.73B | Emerging |